Eggers, Carsten
,
Dano, R.
Schill, J.
Fink, G. R.
Hellmich, M.
Timmermann, L.
Funding for this research was provided by:
Teva Pharmaceutical Industries
UCB
Abbott Pharmaceuticals
Bayer HealthCare
Medtronic
Archimedes Pharma
ZurRosePharma
Article History
Received: 4 October 2017
Revised: 15 January 2018
Accepted: 19 January 2018
First Online: 1 February 2018
Compliance with ethical standards
:
: C. Eggers has received honoraria for speaking engagements and consultancy from Abbvie Pharma, Bial Pharma, Medtronic, Zambon Pharma, TEVA Pharma, GE Healthcare, and UCB Pharma. The institution of C. Eggers, not C. Eggers himself, received funding by the German Research Foundation (DFG) via the Clinical Research Group 219, the medical faculty of the University of Cologne via the “Köln Fortune program”, Medtronic Inc. and the German Parkinson Foundation (Deutsche Parkinson Vereinigung). R. Dano has no conflicts of interest. J. Schill has no conflicts of interest. G.R. Fink receives royalties from the publication of the book Funktionelle MRT in Psychiatrie und Neurologie and Neurologische Differentialdiagnose; received honoraria for speaking engagements from Bayer, TEVA, GlaxoSmithKline, and Boehringer Ingelheim; and receives research support from the Bundesministerium für Bildung und Forschung, the Deutsche Forschungsgemeinschaft and the Marga- and Walter-Boll Foundation. M. Hellmich has no conflicts of interest. L. Timmermann is consultant for Medtronic Inc, Boston Scientific, Bayer Healthcare, UCB Schwarz Pharma, received honoraria in symposia sponsored by TEVA Pharma, Lundbeck Pharma, Bracco, Gianni PR, Medas Pharma, UCB Schwarz Pharma, Desitin Pharma, Boehringer Ingelheim, GlaxoSmithKline, Eumecom, Orion Pharma, Medtronic, Boston Scientific, Cephalon, Abbott, and GE Medical. The institution of Prof. Timmermann, not Prof. Timmermann himself, received funding by the German Research Foundation (DFG) via the Clinical Research Group 219, the German Ministry of Education and Research (BMBF), Manfred und Ursula Müller Stiftung, Klüh Stiftung, Hoffnungsbaum e. V., NBIA DISORDERS SOCIETY USA, the medical faculty of the University of Cologne via the “Köln Fortune program”, Medtronic Inc. and the German Parkinson Foundation (Deutsche Parkinson Vereinigung).
: The study was approved by the local ethics committee of the medical faculty of the University of Cologne (No. 11-233).